2018, Vol. 2 Issue 4, Part APages: 22-25
Antidiabetic efficacy of Habbul aas (Myrtus communis): Case report
Farooqui Shazia Parveen, MA Siddiqui, Khalil Ahmed, MA Quamri, Manumula Komala and Sayed Abuzar Gaffari
Viewed: 1404 - Downloaded: 706
Type 2 diabetes mellitus (DM) is a chronic metabolic disorder in which prevalence has been increasing steadily all over the world. As a result of this trend, it is fast becoming an epidemic in some countries of the world with the number of people affected expected to double in the next decade due to increase in ageing population, thereby adding to the already existing burden for healthcare providers, especially in poorly developed countries. Worldwide, people are less physically active and this has become a leading risk factor for ill health as millions of lives are lost per year due to physical inactivity which leads to a host of disorders and DM is one of the four major NCDs (Cancer, Diabetes, Chronic respiratory and Cardiovascular diseases) which account for most of the disease burden and premature mortality in the European Region. The WHO has projected that diabetes will be the 7th cause of death by 2030. A patient 34years-old Muslim woman was screened as diabetis mellitus. Patient attended National institute of Unani medicine with complain of Polyuria, polyphagia and burning sensation in a feet. A single drug was used in powdered form for 60 days.
The results was assessed after taking unani drug suggested reduction in serum FBS and PPBS level in 60 days. In this case report, we suggested a significant result of Safoofe Habbul Aas for Type 2 diabetes mellitus (DM). By this study, this single unani drug can be used as boon choice therapy for Type 2 diabetes mellitus (DM).
How to cite this article:
Farooqui Shazia Parveen, MA Siddiqui, Khalil Ahmed, MA Quamri, Manumula Komala, Sayed Abuzar Gaffari. Antidiabetic efficacy of Habbul aas (Myrtus communis): Case report. Int J Unani Integ Med 2018;2(4):22-25.